Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

AZD8075 Single Ascending Dose Study

This study has been terminated.
(After reports of turbidity in urine in 4 of 8 volunteers in the 4th cohort, the study was halted temporarily.)
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00787072
First received: November 6, 2008
Last updated: November 30, 2010
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2009
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)